1. Pfeffer JM, Pfeffer MA, Fletcher PJ, Braunwald E. Progressive ventricular remodeling in rats with myocardial infarction. Am J Physiol. 1991; 26.
260:H1406 –H1414.
2. Capasso JM, Li P, Zhang X, Anversa P. Heterogeneity of ventricular
remodeling after acute myocardial infarction in rats. Am J Physiol. 1992;262: 27.
H486 –H495.
3. Rundqvist B, Elam M, Bergmann-Sverrisdottir Y, Eisenhofer G, Friberg P.
Increased cardiac adrenergic drive precedes generalized sympathetic acti- 28.
vation in human heart failure. Circulation. 1997;95:169 –175.
4. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism
of disease progression in heart failure. J Am Coll Cardiol. 1992;20:248 –254. 29.
5. Heidenreich PA, Lee TT, Massie BM. Effect of -blockade on mortality in
patients with heart failure: a meta-analysis of randomized clinical trials. J Am
Coll Cardiol. 1997;30:27–34. 30.
6. Leenen FHH, Huang BS, Yu H, Yuan B. Brain “ouabain” mediates sympathetic hyperactivity in congestive heart failure. Circ Res. 1995;77:993–1000.
7. Zhang W, Huang BS, Leenen FHH. Brain renin-angiotensin system and 31.
sympathetic hyperactivity in rats after myocardial infarction. Am J Physiol.
1999;276:H1608 –H1615.
8. DiBona GF, Jones SY, Brooks VL. ANG II receptor blockade and arterial
32.
baroreflex regulation of renal nerve activity in cardiac failure. Am J Physiol.
1995;269:R1189 –R1196.
9. Leenen FHH, Yuan B, Huang BS. Brain “ouabain” and angiotensin II
33.
contribute to cardiac dysfunction after myocardial infarction. Am J Physiol.
1999;277:H1786 –H1792.
10. Leenen FHH, Skarda V, Yuan B, White R. Changes in cardiac angiotensin II
34.
post myocardial infarction in rats: effects of nephrectomy and ACE inhibitors. Am J Physiol. 1999;45:H317–H325.
35.
11. McKinley MJ, McAllen RM, Mendelsohn FAO, Allen AM, Chai SY,
Oldfield BJ. Circumventricular organs: Neuroendocrine interfaces between
36.
the brain and the hemal milieu. Front Neuroendocrinol. 1990;11:91–127.
12. Li Z, Iwai M, Wu L, Shiuchi T, Jinno T, Cui TX, Horiuchi M. Role of AT2 37.
receptor in the brain in regulation of blood pressure and water intake. Am J
Physiol. 2003;284:H116 –H121.
13. Sadoshima J. Novel AT1-receptor-independent functions of losartan. Circ 38.
Res. 2002;90:754 –756.
14. Schinke M, Baltatu O, Bohm M, Peters J, Rascher W, Bricca G, Lippoldt A,
Ganten D, Bader M. Blood pressure reduction and diabetes insipidus in 39.
transgenic rats deficient in brain angiotensinogen. Proc Natl Acad Sci U S A.
1999;96:3975–3980.
